Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 5 for:    esbriet | scleroderma
Previous Study | Return to List | Next Study

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate (SLSIII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03221257
Recruitment Status : Active, not recruiting
First Posted : July 18, 2017
Last Update Posted : October 12, 2020
Sponsor:
Collaborators:
University of Michigan
Genentech, Inc.
University of California, Los Angeles
Information provided by (Responsible Party):
Michael Roth, University of California, Los Angeles

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 15, 2022
Estimated Study Completion Date : June 1, 2022
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):